ORTINGLOBE16.30

ORTIN GLOBAL LIMITED

· Pharma & Health
₹ CrorePeersLASAMANGALAMBIOFILCHEMVINEETLABKREBSBIOALPABALPHARMANATCAPSUQMcap ₹13.3 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment0.00.00.00.0
+ Other Non-current Financial Assets0.20.80.8
Non-current Financial Assets0.20.00.80.8
+ Deferred Tax Assets0.10.00.0
Total Non-current Assets0.20.10.80.8
Current Assets
+ Inventories0.10.00.00.0
+ Trade Receivables1.80.30.20.2
+ Cash & Cash Equivalents0.50.40.60.6
+ Other Bank Balances1.90.00.00.0
+ Other Current Financial Assets0.4
Current Financial Assets4.11.00.80.8
+ Other Current Assets2.22.73.03.0
Total Current Assets6.33.73.83.8
Total Assets6.63.84.64.6
Equity
+ Equity Share Capital8.18.18.18.1
+ Other Equity / Reserves-5.3-6.2-6.9-6.9
Equity — Owners of Parent2.82.01.21.2
Total Equity2.82.01.21.2
Liabilities
+ Borrowings — Non-current1.80.31.01.0
Non-current Financial Liabilities1.80.31.01.0
+ Deferred Tax Liabilities-0.1
Non-current Liabilities1.70.31.01.0
+ Trade Payables0.10.00.00.0
+ Other Current Financial Liab1.5
Current Financial Liabilities0.11.60.00.0
+ Provisions — Current0.00.00.00.0
+ Current Tax Liabilities0.2
+ Other Current Liabilities1.82.42.4
Current Liabilities2.01.62.42.4
Total Liabilities3.81.83.43.4
Total Equity & Liabilities6.63.84.64.6
Trade Payables — MSME split
+ Dues to Other Creditors — Current0.00.00.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.